Proteomics Panel Not Useful for Predicting Hypertensive Disorders of Pregnancy
By Elana Gotkine HealthDay Reporter
THURSDAY, July 11, 2024 -- Large-scale proteomics in early pregnancy is not clinically useful for risk prediction of hypertensive disorders of pregnancy (HDP), according to a study published online July 3 in JAMA Cardiology.
Philip Greenland, M.D., from the Feinberg School of Medicine at Northwestern University in Chicago, and colleagues conducted a nested case-control study to examine the predictive ability of large-scale proteomics for prediction of HDP in early pregnancy. Nulliparous individuals during first-trimester clinical visits were included; cases were those with HDP, while controls were selected from those who delivered at or after 37 weeks without any HDP, preterm birth, or small-for-gestational-age infants. Data were included for 753 HDP cases and 1,097 controls. An aptamer-based assay that included 6,481 unique human proteins was performed on stored plasma.
The elastic net model was used to adjust protein-based models for clinical and demographic variables. Using this approach, the researchers found no proteins were selected for augmenting the clinical and demographic covariates. Modest predictive performance was seen for the resulting model, with areas under the curve of 0.64 and 0.62 for the training and test sets, respectively. Only minimal changes were yielded with further adjustment for study site.
"In this case-control study with detailed clinical data and stored plasma samples available in the first trimester, an aptamer-based proteomics panel did not meaningfully add to predictive utility over and above clinical and demographic factors that are routinely available," the authors write.
Several authors disclosed ties to the pharmaceutical industry.
Abstract/Full Text (subscription or payment may be required)
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
© 2025 HealthDay. All rights reserved.
Posted July 2024
Read this next
Prenatal PFAS Exposure Linked to Elevated BP Through Adolescence
MONDAY, June 16, 2025 -- Prenatal exposure to specific perfluoroalkyl and polyfluoroalkyl substances (PFAS) is associated with offspring blood pressure (BP) through age 18 years...
New Mothers Face Significant Loss of Uninterrupted Sleep
THURSDAY, June 12, 2025 -- New mothers face a significant loss of uninterrupted sleep through week 13 postpartum, according to a study presented at SLEEP 2025, the...
Increasing Proportion of U.S. Adults Unaware They Have Hypertension
MONDAY, June 9, 2025 -- From 2013 to 2023, there was an increase in the proportion of U.S. adults who were unaware of having hypertension, according to a research letter published...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.